Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Chiara, Biasoli"'
Autor:
Guendalina Graffigna, Serena Barello, Caterina Bosio, Chiara Biasoli, Andrea Buzzi, Cristina Cassone, Luigi Ambroso, Patrizia Di Gregorio, Lorenzo Farace, Paola Giordano, Renato Marino, Irene Ricca, Angiola Rocino
Publikováno v:
AboutOpen, Vol 9, Iss 1 (2022)
About 5000 people in Italy suffer from hemophilia, the most common coagulation disorder. As for other chronic diseases, even in the case of hemophilia, the engagement of the patient is essential: the patients, in fact, must be empowered and helped to
Externí odkaz:
https://doaj.org/article/2d3f8e1cf0674f608258678b54705677
Autor:
Annarita Tagliaferri, Angelo Claudio Molinari, Flora Peyvandi, Antonio Coppola, Francesco Demartis, Chiara Biasoli, Alessandra Borchiellini, Dorina Cultrera, Raimondo De Cristofaro, Filomena Daniele, Paola Giordano, Emanuela Marchesini, Maurizio Margaglione, Renato Marino, Berardino Pollio, Paolo Radossi, Cristina Santoro, Rita Carlotta Santoro, Sergio Siragusa, Gianluca Sottilotta, Alberto Tosetto, Lydia Piscitelli, Maria Rosaria Villa, Ezio Zanon, Adele Finardi, Irene Schiavetti, Daniella Vaccari, Giancarlo Castaman
Publikováno v:
Haemophilia. 29:135-144
Introduction: Factor IX replacement therapy is used for treatment and prophylaxis of bleeding in haemophilia B. rIX-FP is an extended half-life albumin-fusion protein, which, in clinical studies, has demonstrated prolonged dosing intervals up to 21 d
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 21, Iss 1 (2020)
Prophylaxis is recognized as the most effective treatment regimen for patients with severe hemophilia A. Prophylaxis with standard half-life (SHL) FVIII products requires frequent intravenous administrations, at least two-three times per week. Freque
Externí odkaz:
https://doaj.org/article/280b437ce64f4c40834341bc1560efa0
Autor:
Marta Monti, Tiziano Martini, Vittorio Pengo, Giovanni Poletti, Paola Pedrazzi, Chiara Biasoli, Maddalena Giovacchini, Tommaso Fasano
Publikováno v:
Seminars in Thrombosis and Hemostasis.
Autor:
Ezio, Zanon, Samantha, Pasca, Gianluca, Sottilotta, Angelo C, Molinari, Antonietta, Ferretti, Patrizia, Di Gregorio, Berardino, Pollio, Michele, Pizzuti, Lucia Dora, Notarangelo, Chiara, Biasoli, Piergiorgio, Cojutti, Federico, Pea, Paolo, Simioni, Flora, Peyvandi
Publikováno v:
Blood transfusion = Trasfusione del sangue.
Congenital factor XIII (FXIII) deficiency is a rare coagulation disorder characterized by muscular or mucocutaneous bleeding with life-threatening intracranial hemorrhages (ICHs), especially in cases with severe disease. The best treatment is the use
Autor:
Ezio Zanon, Samantha Pasca, Francesco Demartis, Annarita Tagliaferri, Cristina Santoro, Isabella Cantori, Angelo Claudio Molinari, Chiara Biasoli, Antonio Coppola, Matteo Luciani, Gianluca Sottilotta, Irene Ricca, Berardino Pollio, Alessandra Borchiellini, Alberto Tosetto, Flora Peyvandi, Anna Chiara Frigo, Paolo Simioni
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 7; Pages: 1969
Background: Intracranial hemorrhage (ICH) is a highly serious event in patients with haemophilia (PWH) which leads to disability and in some cases to death. ICH occurs among all ages but is particularly frequent in newborns. Aim: The primary aim was
Autor:
Paolo Angelo Cortesi, Angiola Rocino, Daniele Preti, Anna Fragomeno, Francesco Cucuzza, Nicola Ceresi, Cristina Santoro, Antonietta Ferretti, Arianna Fornari, Ippazio Cosimo Antonazzo, Rita Facchetti, Paolo Cozzolino, Chiara Biasoli, Cristina Cassone, Antonio Coppola, Lorenzo G. Mantovani
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(2)
Introduction: Haemophilia management and patients’ quality of life significantly improved. However, data on current patients’, caregivers’ and clinicians’ satisfaction and limitations of treatments and haemophilia management are limited. Aim:
Publikováno v:
Medicina dello Sport. 74
Autor:
Federica Riccardi, Antonio Coppola, Gianna Franca Rivolta, Annalisa Matichecchia, Gabriele Quintavalle, Chiara Biasoli, Lelia Valdrè, Lydia Piscitelli, Antonio Percesepe, Annarita Tagliaferri
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(2)
Haemophilias are X-linked inherited bleeding disorders, due to de novo F8/F9 gene variants in 30-50% of cases. The identification of causative variant in index cases (IC) is crucial for genetic counselling in related women. Over the last 20 years the
Autor:
Elena Santagostino, Annarita Tagliaferri, Maria Elisa Mancuso, Giancarlo Castaman, Maurizio Margaglione, Pier Mannuccio Mannucci, Silvia Linari, Ezio Zanon, Giovanni Di Minno, Chiara Biasoli, Antonio Coppola, Angiola Rocino, Cristina Santoro
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(1)
BACKGROUND Immune tolerance induction (ITI) is the only proven strategy to eradicate factor VIII inhibitors in patients with haemophilia A (HA). AIM To identify patients and treatment options with the highest chance of inhibitor eradication by primar